Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

No abstract is available for this paper.

• Publication year

  1997

• Venue

  The Lancet

• Publication date

  1997-12-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(97)05535-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.

  1997cited by this paper
• Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.

  1996cited by this paper
• Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor.

  1996cited by this paper
• Cytomegalovirus prophylaxis in solid organ transplant recipients.

  1996cited by this paper
• Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS

  1995cited by this paper
• OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation.

  1995cited by this paper
• Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection.

  1995cited by this paper
• Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients

  1995cited by this paper
• Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients.

  1995cited by this paper
• Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.

  1995cited by this paper
• Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group.

  1995cited by this paper
• High-Dose Acyclovir Compared with Short-Course Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Liver Transplant Recipients

  1994cited by this paper
• A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR‐HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS

  1994cited by this paper
• Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

  1993cited by this paper
• Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant

  1993cited by this paper
• Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation

  1993cited by this paper
• Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis.

  1993cited by this paper
• THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTS

  1993cited by this paper
• Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients.

  1993cited by this paper
• Donated organ as a source of cytomegalovirus in orthotopic liver transplantation

  1992cited by this paper
• A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.

  1992cited by this paper
• A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy.

  1992cited by this paper
• Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection.

  1991cited by this paper
• Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients.

  1991cited by this paper
• A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.

  1989cited by this paper
• Clinical patterns of cytomegalovirus disease after liver transplantation.

  1989cited by this paper
• Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.

  1989cited by this paper
• Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.

  1988cited by this paper
• Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.

  1988cited by this paper
• Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.

  1987cited by this paper

• Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

  2025cites this paper
• Efficacy and toxicity analysis of ganciclovir in patients with cytomegalovirus lung infection: what is new for target range of therapeutic drug monitoring

  2025influential citation
• Long-term prognosis following cytomegalovirus respiratory infection in immunocompromised and immunocompetent patients: a retrospective single-centre study

  2025cites this paper
• The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation

  2024cites this paper
• Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: systematic review and meta-analysis of randomized controlled trials

  2024cites this paper
• Detecting drug-resistant human cytomegalovirus mutations in liver transplant recipients: A study of the UL97 gene

  2024cites this paper
• Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study

  2024cites this paper
• Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients: Guidelines by the Korean Society of Infectious Diseases and the Korean Society for Transplantation

  2024cites this paper
• Epidemiology and Management of Infections in Liver Transplant Recipients

  2024cites this paper
• Optimizing the approach to monitoring allograft inflammation using serial urinary CXCL10/creatinine testing in pediatric kidney transplant recipients

  2024cites this paper
• Incidence of valganciclovir‐related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease

  2024cites this paper
• Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults

  2024cites this paper
• Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan.

  2024cites this paper
• Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

  2024cites this paper
• Human cytomegalovirus‐related gastrointestinal disease after kidney transplantation: A systematic review

  2023cites this paper
• Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

  2023cites this paper
• A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma.

  2023cites this paper
• Risk Factors for Cytomegalovirus Infection and Its Impact on Survival after Living Donor Liver Transplantation in South Korea: A Nested Case-Control Study

  2023cites this paper
• Investigating infectious outcomes in adult patients undergoing solid organ transplantation: A retrospective single-center experience, Paris, France

  2023cites this paper
• Infectious Complications After A Liver Transplant

  2023cites this paper
• A New Duplication in 668 to 672 Sites of UL54 Gene in Cytomegalovirus Ganciclovir Resistant Liver Transplanted Patients

  2023cites this paper
• Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis

  2023cites this paper
• Cytomegalovirus infection in liver-transplanted children

  2022cites this paper
• Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center

  2022cites this paper
• Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation—A Network Meta-Analysis

  2022cites this paper
• Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV)

  2021cites this paper
• Anti-infection Strategies

  2021cites this paper
• Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients

  2021cites this paper
• Evaluation of cytomegalovirus prophylaxis in low and intermediate risk kidney transplant recipients receiving lymphocyte‐depleting induction

  2021cites this paper
• Central Nervous System Infections in the Immunocompromised Adult Presenting to the Emergency Department.

  2021cites this paper
• Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients

  2021cites this paper
• Hepatitis A and Other Viral Infections

  2020cites this paper
• Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function

  2020cites this paper
• Cytomegalovirus infection after liver transplantation

  2020cites this paper
• Prevention of cytomegalovirus infection after solid organ transplantation: a Bayesian network analysis

  2020cites this paper
• Lebertransplantation

  2020cites this paper
• Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipients

  2020cites this paper
• IL28B rs12979860 T allele protects against CMV disease in liver transplant recipients in the post‐prophylaxis and late period

  2019cites this paper
• ESITRA-SEIMC / REIPI recommendations for the management of cytomegalovirus nfection in solid-organ transplant patients

  2019cites this paper
• Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Infection in Kidney Transplant Recipients

  2019cites this paper
• Clinical practice guidelines for the provision of renal service in Hong Kong: Infection Control in Renal Service

  2019cites this paper
• Ganciclovir Therapeutic Drug Monitoring: A Case Series

  2019cites this paper
• Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives

  2018cites this paper
• Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.

  2018cites this paper
• Infections in Liver Transplantation

  2018cites this paper
• Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post‐transplant outcome: A single center experience

  2018cites this paper
• Systematic review of ganciclovir pharmacodynamics during the prevention of cytomegalovirus infection in adult solid organ transplant recipients

  2018cites this paper
• Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell‐Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury

  2018cites this paper
• New therapies for human cytomegalovirus infections.

  2018cites this paper
• Risk factors for allograft failure in liver transplant recipients

  2018cites this paper
• The Activation of Cytomegalovirus and Human Herpes Virus 6 After Liver Transplantation

  2018cites this paper
• Manipulation of Viral MicroRNAs as a Potential Antiviral Strategy for the Treatment of Cytomegalovirus Infection

  2017cites this paper
• Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients

  2017cites this paper
• An introduction to gastrointestinal tract CMV disease

  2017cites this paper
• Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients: A Prospective Pharmacokinetic Study

  2017cites this paper
• Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film‐coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease

  2017cites this paper
• Incidence and risk factors for cytomegalovirus in kidney transplant patients in Babol, northern Iran

  2017cites this paper
• Cytomegalovirus Infection in Liver Transplant Recipients: Current Approach to Diagnosis and Management.

  2017influential citation
• Letermovir for the management of cytomegalovirus infection

  2017cites this paper
• Clinical Outcomes with Antiviral Prophylaxis or Preemptive Therapy for Cytomegalovirus Disease after Liver Transplantation: A Systematic Review and Meta-Analysis.

  2017cites this paper
• Viral Infections in Organ Transplant Recipients

  2017cites this paper
• Cytomegalovirus in the Pediatric Transplant Recipient: Where Are We Now?

  2017cites this paper
• Cytomegalovirus Infection in Ireland: Seroprevalence, HLA Class I Alleles, and Implications.

  2016cites this paper
• Cytomegalovirus infection after solid organ transplantation

  2016cites this paper
• Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

  2016cites this paper
• Cytomegalovirus Treatment Strategy After a Liver Transplant: Preemptive Therapy or Prophylaxis for Cytomegalovirus Seropositive Donor and Recipient.

  2016cites this paper
• Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

  2016cites this paper
• CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS

  2016cites this paper
• Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients.

  2016cites this paper
• Risks and Epidemiology of Infections After Liver Transplantation

  2016cites this paper
• Enfermedades Infecciosas y Microbiología Clínica

  2016cites this paper
• Cytomegalovirus Infection in Ireland

  2016cites this paper
• Two strategies for prevention of cytomegalovirus infections after liver transplantation.

  2016cites this paper
• Resistant cytomegalovirus infection in related donor kidney allograft recipients

  2016cites this paper
• Global and CMV-specific Immune Assays to Predict Clinical Outcomes and Inform Clinical Practice in Solid Organ Transplant Recipients

  2016cites this paper
• Risk factors for ganciclovir-induced thrombocytopenia and leukopenia.

  2015cites this paper
• It's not too late: a proposal to standardize the terminology of “late‐onset” cytomegalovirus infection and disease in solid organ transplant recipients

  2015cites this paper
• Delayed‐onset cytomegalovirus disease coded during hospital readmission in a multicenter, retrospective cohort of liver transplant recipients

  2015cites this paper
• Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults

  2015cites this paper
• Successful Treatment of Herpes Esophagitis With Ganciclovir in a Liver Transplant Patient

  2015cites this paper
• Universal Prophylaxis or Preemptive Strategy for Cytomegalovirus Disease After Liver Transplantation: A Systematic Review and Meta‐Analysis

  2015cites this paper
• Chapter 78 – Infections After Transplantation

  2015cites this paper
• Prophylaxis versus pre‐emptive treatment for prevention of cytomegalovirus infection in CMV‐seropositive orthotopic liver‐transplant recipients

  2015cites this paper
• Pulmonary Complications of Stem Cell and Solid Organ Transplantation

  2015cites this paper
• Successful Cost-Effective Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients Using Low-Dose Valganciclovir.

  2015cites this paper
• The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation

  2015cites this paper
• Liver Immunology: Principles and Practice

  2015cites this paper
• 311 – Risk Factors and Approaches to Infections in Transplant Recipients

  2015cites this paper
• Relations exposition-effets et pharmacogénétique du ganciclovir chez le patient transplanté

  2015cites this paper
• Management of cytomegalovirus infection and disease in liver transplant recipients.

  2014cites this paper
• Cytomegalovirus reactivation and preemptive therapy after liver transplant.

  2014cites this paper
• A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant.

  2014cites this paper
• Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis

  2014cites this paper
• Risk factors of cytomegalovirus infection after pediatric liver transplantation.

  2014cites this paper
• Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients

  2013cites this paper
• Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

  2013cites this paper
• Cytomegalovirus in Solid Organ Transplantation

  2013cites this paper
• Prevention of cytomegalovirus following solid organ transplantation: A literature review

  2013cites this paper